Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Parker

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Pharmacology|September 6, 2021
Population Pharmacokinetics of Vancomycin and Meropenem in Pediatric Extracorporeal Membrane Oxygenation SupportBrenda Zylbersztajn, Suzanne Parker, Daniel Navea, et al.
Critical Care (London, England)|June 8, 2019
Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patientsFekade B Sime, Catherine J Byrne, Suzanne Parker, et al.
Clinical Pharmacokinetics|February 28, 2023
Population Pharmacokinetics and Dosing Simulations of Ampicillin and Sulbactam in Hospitalised Adult PatientsEko Setiawan, Menino Osbert Cotta, Mohd-Hafiz Abdul-Aziz, et al.
Archives of Internal Medicine|August 19, 2007
The impact of standardized order sets and intensive clinical case management on outcomes in community-acquired pneumoniaSteven Fishbane, Michael S Niederman, Colleen Daly, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2018
<i>Ex Vivo</i> Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and VaborbactamFekade B Sime, Saurabh Pandey, Nermin Karamujic, et al.
Asia-Pacific Journal of Clinical Oncology|March 8, 2019
First-in-human phase I study of infusional and bolus schedules of Deflexifol, a novel 5-fluorouracil and leucovorin formulation, after failure of standard treatmentPhilip R Clingan, Stephen P Ackland, Daniel Brungs, et al.
The Annals of Thoracic Surgery|March 16, 2022
Perioperative Cefazolin Prophylaxis in Pediatric Cardiac Surgery: A Prospective, Cohort StudyJessica Suna, Gregory Moloney, Supreet P Marathe, et al.
Anaesthesia, Critical Care & Pain Medicine|October 31, 2025
Population pharmacokinetics of cefazolin administered as prophylaxis in paediatric patients undergoing cardiac surgeryVesa Cheng, Jessica Suna, Xin Liu, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2024
Population pharmacokinetics of piperacillin-tazobactam in the plasma and cerebrospinal fluid of critically ill patientsNilesh Kumta, Aaron J Heffernan, Menino Osbert Cotta, et al.
Antimicrobial Agents and Chemotherapy|December 8, 2023
Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO studyEmmanuel Novy, Mohd H Abdul-Aziz, Vesa Cheng, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Pharmacology|September 6, 2021
Population Pharmacokinetics of Vancomycin and Meropenem in Pediatric Extracorporeal Membrane Oxygenation SupportBrenda Zylbersztajn, Suzanne Parker, Daniel Navea, et al.
Critical Care (London, England)|June 8, 2019
Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patientsFekade B Sime, Catherine J Byrne, Suzanne Parker, et al.
Clinical Pharmacokinetics|February 28, 2023
Population Pharmacokinetics and Dosing Simulations of Ampicillin and Sulbactam in Hospitalised Adult PatientsEko Setiawan, Menino Osbert Cotta, Mohd-Hafiz Abdul-Aziz, et al.
Archives of Internal Medicine|August 19, 2007
The impact of standardized order sets and intensive clinical case management on outcomes in community-acquired pneumoniaSteven Fishbane, Michael S Niederman, Colleen Daly, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2018
<i>Ex Vivo</i> Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and VaborbactamFekade B Sime, Saurabh Pandey, Nermin Karamujic, et al.
Asia-Pacific Journal of Clinical Oncology|March 8, 2019
First-in-human phase I study of infusional and bolus schedules of Deflexifol, a novel 5-fluorouracil and leucovorin formulation, after failure of standard treatmentPhilip R Clingan, Stephen P Ackland, Daniel Brungs, et al.
The Annals of Thoracic Surgery|March 16, 2022
Perioperative Cefazolin Prophylaxis in Pediatric Cardiac Surgery: A Prospective, Cohort StudyJessica Suna, Gregory Moloney, Supreet P Marathe, et al.
Anaesthesia, Critical Care & Pain Medicine|October 31, 2025
Population pharmacokinetics of cefazolin administered as prophylaxis in paediatric patients undergoing cardiac surgeryVesa Cheng, Jessica Suna, Xin Liu, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2024
Population pharmacokinetics of piperacillin-tazobactam in the plasma and cerebrospinal fluid of critically ill patientsNilesh Kumta, Aaron J Heffernan, Menino Osbert Cotta, et al.
Antimicrobial Agents and Chemotherapy|December 8, 2023
Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO studyEmmanuel Novy, Mohd H Abdul-Aziz, Vesa Cheng, et al.
Pageof 2